Physician profile
Michael Benz
NPI 1548352438
$39,704.54
in general payments reported to CMS, 2019-2025
28 companies · $5,145 in 2025
The $5,145 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,473 · 2020: $4,099 · 2021: $4,730 · 2022: $7,784 · 2023: $4,247 · 2024: $6,227 · 2025: $5,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,629 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Travel and Lodging: $2,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,629.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Travel and Lodging | $2,239.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13,389.91 | 2019-2025 | Lifevest |
| Abbott Laboratories | $7,871.02 | 2019-2025 | Triclip, Jot Dx, Aveir |
| Edwards Lifesciences Corporation | $6,241.20 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $2,552.45 | 2021-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan, Endurant Iis |
| Zoll Circulation INC | $1,767.33 | 2022-2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Glaxosmithkline, LLC. | $1,011.57 | 2019-2024 | Arexvy |
| Abiomed | $997.96 | 2019-2025 | Impella |
| Boston Scientific Corporation | $948.29 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $730.54 | 2019-2023 | Farxiga |
| Medtronic Vascular, INC. | $715.14 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $550.41 | 2019-2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $473.57 | 2019-2024 | Jardiance |
| Cardiovascular Systems INC. | $376.37 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $371.22 | 2021-2023 | Xarelto |
| Inari Medical, INC. | $270.72 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $210.86 | 2024-2025 | |
| Shockwave Medical, INC | $194.52 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $184.43 | 2022-2024 | Gore Cardioform Septal Occluder |
| Impulse Dynamics (USA) INC. | $135.34 | 2024 | Optimizer |
| Philips North America LLC | $122.55 | 2019 | |
| Cardiva Medical, INC. | $122.25 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $118.40 | 2019 | |
| Pfizer INC. | $110.29 | 2019 | |
| Biosense Webster, INC. | $99.31 | 2023 | Carto 3 |
| Allergan, INC. | $78.28 | 2020-2021 | |
| Stryker Corporation | $24.38 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $21.85 | 2021 | |
| Cordis US Corp. | $14.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Benz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.